We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acceptance and Commitment Therapy for Smoking Cessation in the Primary Care Setting (ACT)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01652508
First Posted: July 30, 2012
Last Update Posted: October 30, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Food and Health Bureau, Hong Kong
Information provided by (Responsible Party):
Dr. Yim Wah Mak, The Hong Kong Polytechnic University
  Purpose
The purpose of this study is to evaluate the feasibility and potential efficacy of Acceptance and Commitment Therapy (ACT) in enhancing smoking cessation among attendees in primary healthcare settings.

Condition Intervention
Smoking Cessation Other: Control Behavioral: Acceptance and Commitment Therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Health Services Research
Official Title: Individual, Telephone-delivered Acceptance and Commitment Therapy for Smoking Cessation in the Primary Healthcare Setting: Feasibility and Potential Efficacy

Resource links provided by NLM:


Further study details as provided by Dr. Yim Wah Mak, The Hong Kong Polytechnic University:

Primary Outcome Measures:
  • 7-day point prevalence by self report [ Time Frame: at 6 months ]
    self-reports on stopped smoking for a consecutive 7 days proceeding to the assessment at 6 months post-intervention


Secondary Outcome Measures:
  • validated self-report not smoking measured [ Time Frame: at 6 months after the baseline ]
    Obtaining CO measurement and testing urinary cotinine for those participants who report quitting smoking


Other Outcome Measures:
  • Feasibility outcomes [ Time Frame: 1 year ]
    Feasibility outcomes will be assessed in terms of participant recruitment, programme attendance and retention, their acceptance of physical cravings, emotions and thoughts related to smoking


Enrollment: 156
Study Start Date: July 2012
Study Completion Date: June 2015
Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Control
Participants are given printed self-help leaflet on smoking cessation developed by the Department of Health, Hong Kong.
Other: Control
Participants in the control group are provided a self-help leaflet on smoking cessation only
Other Name: Control intervention
Experimental: Acceptance and Commitment Therapy
All participants are given a self-help leaflet on smoking cessation. Participants are also given an initial session of face-to-face ACT at a primary health service clinic. In addition, two more subsequent ACT sessions are provided by telephone at one week and one month after the initial intervention.
Behavioral: Acceptance and Commitment Therapy
All participants are given an initial smoking cessation session via face to face by Acceptance and Commitment Therapy. Two other sessions using the same therapy will be provided by telephone. The total contact time by ACT will be 45 mins (15 mins per session).

Detailed Description:
The program is preventive and corrective, and carries brief messages by approaching and influencing services attendees who may not be able to reach in traditional reactive approach method of service users. Those traditional approaches are, for example, quitline and smoking cessation clinic. It can therefore benefit a larger population at low cost.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • aged 18 years and older
  • currently smoking at least one cigarette per day in the past 30 days
  • Hong Kong residents
  • able to communicate in Cantonese
  • currently residing in Hong Kong and expecting to continue to do so for the next 6 months
  • have access to a telephone

Exclusion Criteria:

  • currently undergoing another smoking cessation or similar program
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01652508


Locations
Hong Kong
School of Nursing, The Hong Kong Polytechnic University
Hung Hom, Kowloon, Hong Kong
United Christian Nethersole Community Health Service, Kwong Fuk Community Health Centre
Tai Po, New Territories, Hong Kong
Heavenly Joy Family Clinic
Tin Shui Wai, New Territories, Hong Kong
Sponsors and Collaborators
The Hong Kong Polytechnic University
Food and Health Bureau, Hong Kong
Investigators
Principal Investigator: YW Mak, PhD School of Nursing, The Hong Kong Polytechnic University
Principal Investigator: AY Loke, PhD School of Nursing, The Hong Kong Polytechnic University
  More Information

Publications:
Responsible Party: Dr. Yim Wah Mak, Assistant Professor, The Hong Kong Polytechnic University
ClinicalTrials.gov Identifier: NCT01652508     History of Changes
Other Study ID Numbers: HHSRF9101421
First Submitted: July 26, 2012
First Posted: July 30, 2012
Last Update Posted: October 30, 2017
Last Verified: October 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Dr. Yim Wah Mak, The Hong Kong Polytechnic University:
smoking cessation
Acceptance and Commitment Therapy
primary care setting
randomised controlled trial